
Dieta helps people who suffer from IBS (estimated 45M in USA) to improve their symptoms by providing personalized digestive health recommendations. Our mobile application captures high-resolution data on their diet, bowel movements, medications, and other factors, and then uses machine learning to generate precise recommendations for their path to relieving symptoms and improving quality of life.

Dieta helps people who suffer from IBS (estimated 45M in USA) to improve their symptoms by providing personalized digestive health recommendations. Our mobile application captures high-resolution data on their diet, bowel movements, medications, and other factors, and then uses machine learning to generate precise recommendations for their path to relieving symptoms and improving quality of life.
Focus: AI-driven personalized care for IBS using a mobile app and data science
Product: Mobile app + admin portal capturing diet, symptoms, meds and stool images with computer-vision
Headquarters: Los Angeles, CA
Founders: Asaf Kraus and Ben Neigher
Employees: Approximately 15
Funding (total): Approximately $2.07M (through 2022)
Irritable bowel syndrome (IBS) / digestive health
2018
Digital health / Healthtech
$1.2M
Participation reported from Techstars, Cedars-Sinai, Verissimo Ventures
$1.9M
Company blog entry reporting $1.9M pre-seed and backing from Techstars, Cedars-Sinai and UnitedHealthcare
$0.07M
Most recent funding date recorded in company snapshot; total funding across rounds given as $2,070,000
“Backed by Techstars and healthcare investors/partners including Cedars-Sinai and UnitedHealthcare; investors listed include Tom Williams, Verissimo Ventures, Headwater Ventures, Althea Ventures and Labor Capital”